Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Authors
Category Primary study
JournalBLOOD
Year 2023
This article has no abstract
Epistemonikos ID: b67170d893d2721a2e1551d018a90c8aee3e2649
First added on: Apr 29, 2024